27 December is the International Day of Epidemic Preparedness. ANRS MIE is at the frontline of this mission.
Last updated on 22 December 2025
On 7 December 2020, in the midst of the Covid-19 pandemic ̶ while the world was on the verge of facing a public health crisis , the United Nations General Assembly adopted a resolution proclaiming 27 December as the International Day of Epidemic Preparedness.
In doing so, it invited ‘all Member States, organizations of the United Nations system and other global, regional and subregional organizations, the private sector and civil society, including non-governmental organizations, academic institutions, individuals and other relevant stakeholders to observe the International Day of Epidemic Preparedness annually in an appropriate manner and in accordance with national contexts and priorities, through education and awareness-raising activities, in order to highlight the importance of the prevention of, preparedness for and partnership against epidemics.’
In the wake of the Covid-19 crisis, ANRS was mandated to combat emerging infectious diseases. In 2021, ANRS became ANRS Emerging infectious diseases (ANRS MIE).
ANRS MIE plays a key role in addressing the devastating effects that infectious diseases and epidemics can have on everyone’s lives, in France, Europe and internationally. To this end, the agency is responsible for supporting, coordinating and funding research on infectious diseases.
In addition to being a key player in preparing responses to future infectious threats, it acts as a leading player, interinstitutional pilot and research accelerator when an epidemic occurs. As such, the agency triggers a dedicated levelled procedure in order to respond proportionately to health crises in France or anywhere else in the world.
ANRS MIE coordinates the European Partnership for Pandemic Preparedness BE READY, whose mission is to strengthen the European Union’s capacity to prevent and respond to infectious disease threats.
This consortium’s cross-disciplinary and interdisciplinary approach to better coordinating research and innovation funding at European level adopts the ‘One Health’ and ‘Global Health’ approaches.
In addition to being specifically responsible for the overall coordination of the consortium, ANRS MIE is responsible for defining the strategic research and innovation agenda.
To better respond to health crises, ANRS MIE and Inserm lead the PROACT EU-Response consortium. This initiative aims to reinforce Europe’s ability to respond to future health emergencies by establishing an adaptive clinical trial network
Because the risk of epidemics can pose a threat to global public health, ANRS MIE is continuing to develop a dynamic international network, mobilised to respond to the scientific priorities of partner countries and address current health challenges.
The agency continues to strengthen its international dimension by reinforcing its partnership with WHO. In 2025, it was entrusted with the coordination of the Collaborative Open Research Consortium (CORC) on filoviruses in order to prevent and respond rapidly to health threats related to Ebola and Marburg, thus becoming a WHO collaborating centre.
Positioning itself as a key player on the international stage, ANRS MIE, in collaboration with the Pasteur Network, will host the International Pandemic Preparedness Secretariat (IPPS) on 27 January 2026 for the presentation of the fifth 100 Days mission (100DM) implementation report. The cornerstone of the 100DM is to establish a procedure for making safe, effective and affordable diagnostics, treatments and vaccines available for mass production within 100 days of the identification of a public health emergency of international concern.
ANRS MIE offers various calls for proposals (AAP) tailored to infectious diseases, whether endemic, emerging or related to health crises.
These various sources of research funding include the PEPR MIE, the GRIPP1 and the BE READY call for projects.
As part of France 2030, ANRS MIE leads the scientific management and implementation of the Priority Research Programme and Equipment for Emerging Infectious Diseases (PEPR MIE). The PEPR MIE calls for proposals aim to support interdisciplinary projects in basic research, research for the development of countermeasures, as well as in public health and the humanities and social sciences, to effectively prevent and control emerging and re-emerging infectious diseases.
Among the research projects supported since 2023, some focus on surveillance and detection (SISP&EAU), risk assessment for re-emerging infectious diseases (DEBS-Plague), preparedness and communication (TICKRISK), acceptability (ACME) and innovation (VORTEX and ANTIVIRESPIR).
The agency is a member of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) alliance. In 2025, the network launched the first joint call for proposals GRIPP 1 (Global Research Improving Pandemic Preparedness), with the aim of supporting networks and clinical trial platforms ready to deal with epidemics, facilitating an agile and effective response in terms of clinical trials, and promoting an equitable research environment.
In 2026, the European BE READY partnership, coordinated by ANRS MIE, will launch its first call for proposals to better prepare Europe for future pandemics. The theme of this joint transnational call is based on ‘advancing knowledge on host and pathogen dynamics to better combat emerging diseases.’ The BE READY call will support innovative, collaborative, interdisciplinary, and transnational research projects.
The prizes are jointly awarded by ANRS MIE and the Société française de virologie.
17 December 2025